As Americans get vaccinated and we start to recover from the COVID-19 crisis, we need to build on what we’ve learned from this and other challenges. America’s biopharmaceutical industry is ready to work with all stakeholders to deliver a stronger, more resilient, affordable, and equitable health care system for all. For a summary of PhRMA’s patient-centered agenda, click here.